Walleye Trading LLC Acadia Pharmaceuticals Inc Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $23,127 - $40,118	1,300 Added 46.43%	4,100 $75,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $147,538 - $225,567	-7,100 Reduced 71.72%	2,800 $87,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $197,980 - $317,965	9,500 Added 2375.0%	9,900 $206,000
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $7,120 - $10,260	-400 Reduced 50.0%	400 $9,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $73,440 - $94,140	-4,500 Reduced 84.91%	800 $15,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $39,760 - $52,164	-2,800 Reduced 34.57%	5,300 $84,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $136,867 - $177,219	-9,700 Reduced 54.49%	8,100 $133,000
Q2 2022 Aug 08, 2022	BUY	$13.01 - $27.22 $37,729 - $78,938	2,900 Added 19.46%	17,800 $251,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $234,528 - $308,000	11,200 Added 302.7%	14,900 $361,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $282,072 - $455,112	-16,800 Reduced 81.95%	3,700 $86,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $323,490 - $507,785	20,500 New	20,500 $341,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $148,755 - $220,289	-4,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $94,146 - $133,640	2,600 Added 123.81%	4,700 $201,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $4,444 - $8,802	200 Added 10.53%	2,100 $76,000
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $44,308 - $53,428	1,900 New	1,900 $51,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $21,021 - $35,594	-1,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $18,616 - $29,796	1,300 New	1,300 $21,000
Q3 2017 Nov 14, 2017	SELL	$29.49 - $38.37 $2,949 - $3,836	-100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $3,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.7B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account